NCT00854659View on ClinicalTrials.gov

A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

June 30, 2009

Conditions
Healthy Volunteers
Interventions
DRUG

ABT-102

BID tablets, 7 days of treatment

DRUG

Placebo

BID tablets, 7 days of treatment

Trial Locations (1)

78744

Site Reference ID/Investigator# 18101, Austin

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY